Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single versus twice-daily ranitidine for morning abdominal pain and nausea in children
IRCT20171211037830N2Phase 2Completed
- Sponsor
- Research and Technology Deputy, Golestan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ranitidine (2 arms), sponsored by Research and Technology Deputy, Golestan University of Medical Sciences. Primary endpoint: Improvement in morning abdominal pain and nausea. Started Mar 2017; status: completed.
02
Drugs
ranitidine
Beyond the preview
Go deeper on IRCT20171211037830N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171211037830N2.